【Pharmaceutical Network Industry DynamicsSince 2023, many multinational instrument and equipment companies, including Mettler Toledo, Thermo Fisher Scientific, and Danaher, have launched new products. As these products are gradually introduced to the market, they will better meet the production needs of industries such as pharmaceuticals.
It is reported that Thermo Fisher Scientific, a global scientific service company, has introduced more than ten new products to the Chinese market since 2023, including the world's first full-spectrum, ultra-high-speed, high-performance Bigfoot Full-Spectrum Ultra-High-Speed Flow Cytometer. Cells sorted by this instrument can be used for molecular biology research, such as qPCR, Western Blot (WB), and cell culture. It is reported that Thermo Fisher Scientific’s Bigfoot Full-Spectrum Ultra-High-Speed Flow Cytometer features high performance and high throughput, and integrates Class II...
Biological Safety CabinetThe product features have greatly improved the efficiency and safety of cell sorting in applications such as immunology, cell and gene therapy research, gene editing, and gene sequencing.
Global precision instrument and scale manufacturer Mettler Toledo has recently achieved an innovative breakthrough in pH measurement technology, developing a new pH measurement technology called X-Chip. This technology uses a solid composite pH sensing element, which boasts excellent mechanical properties, is almost unbreakable, and offers stable and reliable measurement performance. A pH electrode refers to a type of electrode that can respond to the activity of hydrogen ions in a solution and generate a potential change.
Sensor, widely used in industries such as pharmaceuticals for monitoring product quality, improving production efficiency, ensuring plant safety, or monitoring wastewater to meet environmental protection requirements. It is reported that traditional glass pH sensors are fragile and cannot be more widely applied in some fields. The X-Chip technology of Mettler Toledo's InPro X1 solves the above bottleneck, which will help users to produce safely, improve quality, and increase efficiency.
Life Science Manufacturing Solutions Provider Danaher showcased the ÄKTA process industrial chromatography system among its new products at the 6th China International Import Expo (CIIE). According to reports, this equipment was developed in response to the rapid growth of the biotech industry, the diversification of bioprocessing, and particularly the increasing demand for high-performance chromatography systems in antibody-related applications beyond traditional uses in recent years. The new generation ÄKTA process is a highly configurable industrial chromatography system designed for process scale-up and large-scale production. With over a million possible configurations, the system’s adaptable design can meet various process requirements. It also features the documentation system required for use in GMP-regulated environments, enabling it to handle more challenging process development. The system is widely used in the production of antibodies, gene therapies, and mRNA-based drugs.
In the Chinese market, with the intensification of population aging and the advancement of the Healthy China strategy, multinational companies continue to have a positive outlook on the Chinese market and are actively expanding their presence in China. For instance, Danaher fully launched its "Create and Elevate China" localization strategy last year. In its "8080" quantitative goals, it explicitly stated that 80% of future product sales in China will be manufactured in China; 80% of raw materials and components used by local factories will be sourced domestically, aiming to drive the coordinated development of upstream and downstream segments of the local health industry chain.
For instance, Shimadzu Corporation, a Japanese-funded enterprise, announced in early August this year the launch of a new project in Suzhou New District, Jiangsu, China, aimed at expanding the production of high-end products.
Mass SpectrometerIncluding general precision analytical instruments and high-end medical device products. This means that the company's pace of "intensifying" its layout in China is also accelerating further.
Disclaimer: Under no circumstances shall the information or opinions expressed in this article constitute investment advice to any person.